Tops & Flops Stocks
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
American Renal Associates Holdings Inc | 1.080% | - | - | - | - | - | - |
Viking Therapeutics Inc | 1.050% | 2.938% | -1.243% | 268.454% | 308.808% | 1243.609% | - |
Travere Therapeutics Inc. | 0.980% | - | - | - | - | - | - |
Prothena Corp. plc | 0.970% | 9.744% | -5.310% | -64.918% | -38.506% | -4.464% | - |
Eiger Biopharmaceuticals Inc | 0.950% | - | - | - | - | - | - |
Sientra Inc. | 0.940% | - | - | - | - | - | - |
Cyberoptics Corp. | 0.930% | - | - | - | - | - | - |
Heska Corp | 0.910% | - | - | - | - | - | - |
Natural Alternat. | 0.880% | 1.770% | -7.258% | -24.342% | 0.000% | -52.869% | -50.260% |
Atricure Inc. | 0.850% | - | - | - | - | - | - |
Anavex Life Sciences Corp | 0.830% | 10.962% | -15.408% | -52.858% | -58.914% | -64.191% | 42.520% |
Cytokinetics Inc. | 0.830% | -0.813% | -6.870% | 71.348% | -20.261% | 177.273% | - |
Lemaitre Vascular Inc | 0.820% | 4.237% | 5.128% | 26.025% | 18.269% | 41.055% | - |
Ani Pharmaceuticals Inc. | 0.810% | 1.639% | -0.800% | 80.233% | 24.498% | 126.277% | -1.242% |
Healthstream Inc. | 0.790% | - | - | - | - | - | - |
VBI Vaccines Inc. | 0.770% | -5.072% | -14.658% | -79.768% | -1.132% | -99.312% | -98.943% |
Lumos Pharma Inc. | 0.710% | 10.317% | 6.923% | -8.553% | -4.795% | -73.524% | -79.143% |
Supernus Pharmaceuticals | 0.710% | 2.899% | -5.960% | -14.970% | 8.397% | 10.078% | -13.678% |
Catalyst Pharmaceutical Partners Inc | 0.710% | 1.670% | -2.064% | -6.729% | -9.910% | 247.136% | 161.389% |
Cara Therapeutics Inc. | 0.700% | 13.166% | -15.009% | -80.518% | 4.110% | -93.339% | -95.935% |
Avid Bioservices Inc | 0.700% | 5.109% | 24.138% | -55.556% | 18.033% | -60.000% | 78.174% |
Axsome Therapeutics Inc | 0.660% | 3.639% | 2.477% | 6.726% | -3.311% | 36.221% | - |
Kezar Life Sciences | 0.650% | 3.356% | -1.282% | -65.315% | -12.000% | -83.686% | - |
Kindred Biosciences Inc. | 0.650% | - | - | - | - | - | - |
Strongbridge Biopharma plc | 0.590% | - | - | - | - | - | - |